Topically applied semaphorin 3A ointment inhibits scratching behavior and improves skin inflammation in NC/Nga mice with atopic dermatitis.
暂无分享,去创建一个
K. Takamori | Y. Suga | M. Tominaga | S. Tengara | A. Kamo | K. Taneda | O. Negi | H. Ogawa
[1] O. Hermine,et al. Inhibitory effect of semaphorin‐3A, a known axon guidance molecule, in the human thymocyte migration induced by CXCL12 , 2012, Journal of leukocyte biology.
[2] E. James,et al. Autoreactive CD4(+) T cells in patients with atopic dermatitis. , 2011, The Journal of allergy and clinical immunology.
[3] H. Mizutani,et al. The role of cytokines/chemokines in the pathogenesis of atopic dermatitis. , 2011, Current problems in dermatology.
[4] T. Chikama,et al. Expression of semaphorin 3A and its receptors during mouse corneal development. , 2010, Biochemical and biophysical research communications.
[5] E. Carstens,et al. Enhanced scratching evoked by PAR-2 agonist and 5-HT but not histamine in a mouse model of chronic dry skin itch , 2010, PAIN®.
[6] H. Murota,et al. Olopatadine Hydrochloride Improves Dermatitis Score and Inhibits Scratch Behavior in NC/Nga Mice , 2010, International Archives of Allergy and Immunology.
[7] D. Bates. Vascular endothelial growth factors and vascular permeability , 2010, Cardiovascular research.
[8] K. Takamori,et al. Recent advances in pathophysiological mechanisms of itch , 2010 .
[9] L. Ellis,et al. Role of Class 3 Semaphorins and Their Receptors in Tumor Growth and Angiogenesis , 2009, Clinical Cancer Research.
[10] Y. Goshima,et al. Semaphorin3A alleviates skin lesions and scratching behavior in NC/Nga mice, an atopic dermatitis model. , 2008, The Journal of investigative dermatology.
[11] K. Takamori,et al. Decreased production of semaphorin 3A in the lesional skin of atopic dermatitis , 2008, The British journal of dermatology.
[12] Atsushi Kumanogoh,et al. Semaphorins and their receptors in immune cell interactions , 2008, Nature Immunology.
[13] K. Takamori,et al. Intraepidermal nerve fibers increase in dry skin of acetone-treated mice. , 2007, Journal of dermatological science.
[14] K. Takamori,et al. A hypothetical mechanism of intraepidermal neurite formation in NC/Nga mice with atopic dermatitis. , 2007, Journal of dermatological science.
[15] S. Kawana,et al. Changes in cutaneous sensory nerve fibers induced by skin-scratching in mice. , 2007, Journal of dermatological science.
[16] M. Kurachi,et al. Effects of high‐affinity nerve growth factor receptor inhibitors on symptoms in the NC/Nga mouse atopic dermatitis model , 2007, The British journal of dermatology.
[17] K. Yasui,et al. A novel atopic dermatitis model induced by topical application with dermatophagoides farinae extract in NC/Nga mice. , 2007, Allergology international : official journal of the Japanese Society of Allergology.
[18] M. Steinhoff,et al. The neurobiology of itch , 2006, Nature Reviews Neuroscience.
[19] R. Paus,et al. Frontiers in pruritus research: scratching the brain for more effective itch therapy. , 2006, The Journal of clinical investigation.
[20] M. Klagsbrun,et al. Neuron Restrictive Silencer Factor NRSF/REST Is a Transcriptional Repressor of Neuropilin-1 and Diminishes the Ability of Semaphorin 3A to Inhibit Keratinocyte Migration* , 2006, Journal of Biological Chemistry.
[21] E. Morita,et al. Increased production of vascular endothelial growth factor in the lesions of atopic dermatitis , 2006, Archives of Dermatological Research.
[22] M. Kurachi,et al. Effects of anti-nerve growth factor antibody on symptoms in the NC/Nga mouse, an atopic dermatitis model. , 2005, Journal of pharmacological sciences.
[23] M. Greaves. Itch in systemic disease: therapeutic options , 2005, Dermatologic Therapy.
[24] H. Fujisawa. Discovery of semaphorin receptors, neuropilin and plexin, and their functions in neural development. , 2004, Journal of neurobiology.
[25] D. Tanelian,et al. Semaphorin3A Inhibits Nerve Growth Factor-Induced Sprouting of Nociceptive Afferents in Adult Rat Spinal Cord , 2004, The Journal of Neuroscience.
[26] Paul C. Letourneau,et al. Nerve Growth Factor and Semaphorin 3A Signaling Pathways Interact in Regulating Sensory Neuronal Growth Cone Motility , 2002, The Journal of Neuroscience.
[27] P. Romeo,et al. Neuropilin-1 in the immune system. , 2002, Advances in experimental medicine and biology.
[28] J. Bos,et al. The 500 Dalton rule for the skin penetration of chemical compounds and drugs , 2000, Experimental dermatology.
[29] K. Hira,et al. NC/Nga Mice: A Mouse Model for Atopic Dermatitis , 1999, International Archives of Allergy and Immunology.
[30] T. Nagasawa,et al. Scratching behavior induced by pruritogenic but not algesiogenic agents in mice. , 1995, European journal of pharmacology.